In contrast to saxagliptin, linagliptin did not change the levels of EPCs in T2DM patients [188, 189], although it was associated with an increment in angiogenic T cells (Tang cells: CD3+CD31+CXCR4+) [189]. This evidence concerns the gene PECAM1 and type 2 diabetes mellitus.